References
- Adamson-Small, L. A., Ignatovich, I. V., Laemmerhirt, M. G., Hobbs, J. A. (2014). Persistent parvovirus B19 infection in non-erythroid tissues: Possible role in the inflammatory and disease process. Virus Res., 190, 8–16.10.1016/j.virusres.2014.06.017
- Adamson, L. A., Fowler, L. J., Ewald, A. S., Clare-Salzler, M. J., Hobbs, J. A. (2014). Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues. J. Med. Virol., 86, 1614–1620.10.1002/jmv.23852
- Ashouri, E., Dabbaghmanesh, M. H., Rowhanirad, S., Bakhshayeshkaram, M., Ranjbar Omrani, G., Ghaderi, A. (2012). Activating KIR2DS5 receptor is a risk for thyroid cancer. Hum. Immunol., 73, 1017–1022.10.1016/j.humimm.2012.07.325
- Barah, F., Vallely, P. J., Chiswick, M. L., Cleator, G. M., Kerr, J. R. (2001). Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet, 358, 729–730.10.1016/S0140-6736(01)05905-0
- Borghi, A., D’Accolti, M., Rizzo, R., Virgili, A., Di Luca, D., Corazza, M., Caselli, E. (2016). High prevalence of specific KIR types in patients with HHV-8 positive cutaneous vascular lesions: A possible predisposing factor? Arch. Dermatol. Res., 308, 373–77.10.1007/s00403-016-1643-x27059715
- Caselli, E., Rizzo, R., Ingianni, A., Contini, P., Pompei, R., Di Luca, D. (2014). High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus’. J. Med. Virol., 86, 1745–1751.10.1002/jmv.2377124122895
- Desailloud, R., Hober, D. (2009). Viruses and thyroiditis: An update. Virol. J.,6,5.10.1186/1743-422X-6-5265487719138419
- Ferrari, S. M., Fallahi, P., Antonelli, A., Benvenga, S. (2017). Environmental issues in thyroid diseases. Front Endocrinol. (Lausanne), 8, 50.10.3389/fendo.2017.00050535762828373861
- Fogel, L. A., Yokoyama, W. M., French, A. R. (2013). Natural killer cells in human autoimmune disorders. Arthritis Res. Ther., 15, 216.10.1186/ar4232397902723856014
- Fusco, C., Guerini, F. R., Nocera, G., Ventrella, G., Caputo, D., Valentino, M. A., Agliardi, C., Gallotti, J., Morra, V. B., Florio, C., Clerici, M., Lombardi, M. L. (2010). KIRs and their HLA ligands in remitting-relapsing multiple sclerosis. J. Neuroimmunol., 229, 232–237.10.1016/j.jneuroim.2010.08.00420826009
- Gómez-Lozano, N., Gardiner, C. M., Parham, P., Vilches, C. (2002). Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics, 54, 314–319.10.1007/s00251-002-0476-212185535
- Heegaard, E. D., Brown, K. E. (2002). Human parvovirus B19. Clin. Microbiol. Rev., 15, 485–505.10.1128/CMR.15.3.485-505.200211808112097253
- Kozireva, S. V., Zestkova, J. V., Mikazane, H. J., Kadisa, A. L., Kakurina, N. A., Lejnieks, A. A., Danilane, I. N., Murovska, M. F. (2008). Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. J. Rheumatol., 35, 1265–1270.
- Marsh, S. G., Parham, P., Dupont, B., Geraghty, D. E., Trowsdale, J., Middleton, D., Vilches, C., Carrington, M., Witt, C., Guethlein, L. A., Shilling, H., Garcia, C. A., Hsu, K. C., Wain, H. (2003). Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens, 62, 79–86.10.1034/j.1399-0039.2003.00072.x12859599
- Middleton, D., Gonzelez, F. (2010). The extensive polymorphism of KIR genes. Immunology, 129, 8–19.10.1111/j.1365-2567.2009.03208.x280748220028428
- Mori, K., Yoshida, K. (2010). Viral infection in induction of Hashimoto’s thyroiditis: A key player or just a bystander? Curr. Opin. Endocrinol. Diabetes Obes., 17, 418–424.10.1097/MED.0b013e32833cf51820625285
- Naciute, M., Mieliauskaite, D., Rugiene, R., Nikitenkiene, R., Jancoriene, L., Mauricas, M., Nora-Krukle, Z., Murovska, M., Girkontaite, I. (2016). Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis. J. Gen. Virol., 97, 3302–3312.10.1099/jgv.0.000621520367327902343
- Page, C., Duverlie, G., Sevestre, H., Desailloud, R. (2015). Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and patho-physiological hypotheses. J. Med. Virol., 87, 162–169.10.1002/jmv.2396324760746
- Pellett, F., Siannis, F., Vukin, I., Lee, P., Urowitz, M. B., Gladman, D. D. (2007). KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens, 69 (Suppl 1.), 106–108.10.1111/j.1399-0039.2006.762_6.x17445179
- Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., Erlich, H. A. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487–491.10.1126/science.24488752448875
- Vilches, C., Parham, P. (2002). KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol., 20, 217–251.10.1146/annurev.immunol.20.092501.13494211861603
- Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., Ugolini, S. (2011). Innate or adaptive immunity? The example of natural killer cells. Science, 331, 44–49.10.1126/science.1198687308996921212348
- Wang, J., Zhang, W., Liu, H., Wang, D., Wang, W., Li, Y., Wang, Z., Wang, L., Zhang, W., Huang, G. (2010). Parvovirus B19 infection associated with Hashimoto’s thyroiditis in adults. J. Infect., 60, 360–370.10.1016/j.jinf.2010.02.00620153771
- Wilson, M. J., Torkar, M., Haude, A., Milne, S., Jones, T., Sheer, D., Beck, S., Trowsdale, J. (2000). Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA,97, 4778–4783.10.1073/pnas.0805885971830910781084